Anticholinergic activity in the serum of patients receiving maintenance disopyramide therapy.

Por Iisalo, E, Aaltonen, L
Publicado em 1984

PTEN and LKB1 genes in laryngeal tumours

Por CHEN, R. W., AVIZIENYTE, E., ROTH, S., LEIVO, I., MAKITIE, A., AALTONEN, L., AALTONEN, L.
Publicado em 1999

Role of TP53 P72R polymorphism in human papillomavirus associated premalignant laryngeal neoplasm

Por Aaltonen, L., Chen, R. W., Roth, S., Makitie, A., Rihkanen, H., Vaheri, A., Aaltonen, L.
Publicado em 2001

Strategies for screening for hereditary non-polyposis colorectal cancer

Por Loukola, A., de la Chapelle, A., Aaltonen, L.
Publicado em 1999

Correction for vol. 36, p. 819

Por LOUKOLA, A., DE LA CHAPELLE, A., AALTONEN, L.
Publicado em 2000

CHEK2 1100delC and colorectal cancer

Por Kilpivaara, O, Laiho, P, Aaltonen, L, Nevanlinna, H
Publicado em 2003

E-cadherin is not frequently mutated in hereditary gastric cancer

Por AVIZIENYTE, E., LAUNONEN, V., SALOVAARA, R., KIVILUOTO, T., AALTONEN, L.
Publicado em 2001

The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers

Por Wheeler, J, Loukola, A, Aaltonen, L, Mortensen, N, Bodmer, W
Publicado em 2000

Telomerase activity is commonly detected in hereditary nonpolyposis colorectal cancers.

Por Li, Z. H., Salovaara, R., Aaltonen, L. A., Shibata, D.
Publicado em 1996

No SMAD4 hypermethylation in colorectal cancer

Por Roth, S, Laiho, P, Salovaara, R, Launonen, V, Aaltonen, L A
Publicado em 2000

A 17p11.2 germline deletion in a patient with Smith-Magenis syndrome and neuroblastoma

Por Hienonen, T, Sammalkorpi, H, Isohanni, P, Versteeg, R, Karikoski, R, Aaltonen, L
Publicado em 2005

Screening for microsatellite instability target genes in colorectal cancers

Por Vilkki, S, Launonen, V, Karhu, A, Sistonen, P, Vastrik, I, Aaltonen, L
Publicado em 2002

CHEK2 I157T associates with familial and sporadic colorectal cancer

Por Kilpivaara, O, Alhopuro, P, Vahteristo, P, Aaltonen, L A, Nevanlinna, H
Publicado em 2006

Blood‐derived gene‐expression profiling in unravelling susceptibility to recessive disease

Por Vahteristo, P, Kokko, A, Saksela, O, Aittomäki, K, Aaltonen, L A
Publicado em 2007

The MDM2 promoter polymorphism SNP309T→G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck

Por Alhopuro, P, Ylisaukko-oja, S, Koskinen, W, Bono, P, Arola, J, Jarvinen, H, Mecklin, J, Atula, T, Kontio, R, Makitie, A, Suominen, S, Leivo, I, Vahteristo, P, Aaltonen, L, Aaltonen, L
Publicado em 2005

Mutation and LOH analysis of ACO2 in colorectal cancer: no evidence of biallelic genetic inactivation

Por Laiho, P, Hienonen, T, Mecklin, J, Jarvinen, H, Karhu, A, Launonen, V, Aaltonen, L
Publicado em 2003

Mutation analysis of SMAD2, SMAD3, and SMAD4 genes in hereditary non-polyposis colorectal cancer

Por ROTH, S, JOHANSSON, M, LOUKOLA, A, PELTOMAKI, P, JARVINEN, H, MECKLIN, J, AALTONEN, L
Publicado em 2000

No evidence of microsatellite instability in bone tumours.

Por Tarkkanen, M., Aaltonen, L. A., Böhling, T., Kivioja, A., Karaharju, E., Elomaa, I., Knuutila, S.
Publicado em 1996

Effects of mutation and growth rates on patterns of microsatellite instability.

Por Li, Z. H., Aaltonen, L. A., Shu, Q., Srivastava, S., Grizzle, W. E., Shibata, D.
Publicado em 1996

Mutation analysis of components of the Mediator kinase module in MED12 mutation-negative uterine leiomyomas

Por Mäkinen, N, Heinonen, H-R, Sjöberg, J, Taipale, J, Vahteristo, P, Aaltonen, L A
Publicado em 2014